Media Coverage

10/31/17
Robert Zivadinov, MD, PhD, professor of neurology, is interviewed in MD Magazine about the TOPIC multiple sclerosis study and Aubagio’s effect of cortical gray matter atrophy (CGMA) loss. The article includes a video interview with Zivadinov, director of the Buffalo Neuroimaging Analysis Center.
9/15/17
David W. Hojnacki, MD, assistant professor of neurology, received the Stephen H. Kelly Award as a “Professional on the Move” at the “Champions on the Move” event sponsored by the Upstate Chapter of the National Multiple Sclerosis Society.
7/25/17
Gil I. Wolfe, MD, professor and Irvin and Rosemary Smith Chair of neurology, talks about myasthenia gravis, a chronic autoimmune neuromuscular disease that often gives people difficulty operating muscles they should be able to control. He said said many people diagnosed with the disease have never heard of it. “In general, people with MG do very well,” he said. “They can hold jobs, they can exercise, they can be active in their family lives.”
7/13/17
An article about a local 17-year-old with congenital muscular dystrophy and his everyday routine of countering the obstacles posed by the disease interviews Nicholas J. Silvestri, MD, clinical associate professor of neurology and a specialist in neuromuscular disorders. “The absence of a particular protein (merosin) forming the muscle membrane leads to progressive destruction of muscle cells over time which are not able to fully repair themselves,” he said.
6/16/17
An article about managing symptoms of multiple sclerosis while pregnant interviews Bianca Weinstock-Guttman, MD, professor of neurology, who said when trying to conceive, it’s generally recommended that women stop taking medications that stave off MS relapses. “But going off medication increases the risk for relapse. So you have to determine which therapy is safest for the mother and baby,” she said.
6/8/17
UB’s Alzheimer’s Disease and Memory Disorders Center is expanding its clinics in Buffalo and Williamsville, and the center, part of UBMD Neurology and the Jacobs School of Medicine and Biomedical Sciences, began seeing patients twice weekly in April, up from once a week. “We treat all stages of dementia, but more and more research is being conducted on mild cognitive impairment and early signs of Alzheimer’s disease with the goal of slowing or even stopping progression of this neurodegenerative disease,” said Kinga Szigeti, MD, PhD, associate professor of neurology and director of the center.
3/31/17
Articles about a study that showed that multiple sclerosis is more likely to progress to advanced disease among patients who suffer from fatigue and limited use of their legs quote Bianca Weinstock-Guttman, MD, professor of neurology.
1/28/17
An article about UB’s Clinical and Translational Science Institute interviews Timothy F. Murphy, MD, director of the institute and senior associate dean for clinical and translational research, and Gil I. Wolfe, MD, professor and Irwin and Rosemary Smith Chair of neurology, about how it is reshaping medical research in Western New York.
12/19/16
Bianca Weinstock-Guttman, MD, professor of neurology, was quoted while commenting on new research that found that patients with multiple sclerosis and other neurological diseases may be at risk of developing problems with bone mineral density.
11/15/16
Research has found that women who have migraines are more likely to suffer heart attacks or strokes later in life, but in a linked editorial, Melissa L. Rayhill, MD, clinical assistant professor of neurology, cautioned that women should not be worried about the link and stressed that individual women were at very low risk, even if they had migraines.
10/18/16
Research shows patients with cluster headaches were generally accepting of placebo-controlled trials of preventive drugs and non-invasive medical devices, but did not support the idea of using a placebo control in preventive surgical trials and abortive treatment trials.
9/29/16
UB hosted a panel discussion on the controversies surrounding the legalization of medical marijuana, featuring Edward Bednarczyk, PharmD, chair of the Department of Pharmacy Practice, as keynote speaker.
9/6/16
A UB study of Myasthenia gravis, an autoimmune disease that causes muscle weakness and fatigue, found that surgical removal of an organ called the thymus reduced patients’ weakness and their need for immunosuppressive drugs.
8/15/16
Research led by Gil Wolfe, MD, professor and Irvin and Rosemary Smith Chair of neurology, shows that removing the thymus gland is an effective treatment for the autoimmune disorder myasthenia gravis.
7/11/16
A new study by researchers led by Robert Zivadinov, MD, PhD, professor of neurology, found that leaky blood vessels in the brain called cerebral microbleeds are associated with an increased risk of physical and cognitive disability in patients with multiple sclerosis.